Ossification of the posterior longitudinal ligament (OPLL) is a progressive spinal disease characterized by ectopic bone ...

Under the terms of the agreement, TG Therapeutics obtains non-exclusive research, clinical and commercial rights to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform. In return, ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

in Ireland for the treatment of adult patients with relapsing multiple sclerosis (RMS) with active disease.1 BRIUMVI® is a novel monoclonal antibody that targets a unique epitope on CD20-expressing ...

Multiple sclerosis (MS ... and about 2.9 million people worldwide. There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, bruises, and sometimes permanent lipoatrophy,” Wyss told more than 800 people ...

Therapy with cladribine tablets was evaluated as a short-course regimen for RRMS in the Cladribine Tablets Treating Multiple Sclerosis Orally (CLARITY) study. [46–49] CLARITY was a Phase III ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis ... MS is a chronic, progressive condition of the central nervous system (CNS) in which your immune system attacks myelin ...

He previously worked at Android Police and Tech Advisor. Google’s AI assistant Gemini is now able to carry out tasks across multiple apps in a single interaction, in an update announced today ...